Accurate Results in the Clinical Laboratory

<p>Section I: Sources of errors in clinical laboratories: An overview<br>1. Variation, errors, and quality in the clinical laboratory<br>2. Errors in patient preparation, specimen collection, anticoagulant and preservative use: how to avoid such pre-analytical errors<br>3. Sample processing and specimen misidentification issues: major sources of pre-analytical errors<br>4. Effect of patient-related factors on clinical laboratory test results<br>5. Interferences of hemolysis, lipemia and high bilirubin on laboratory tests<br>6. Immunoassay design<br>7. Overview of other sources of interferences in immunoassays: prozone effect and interferences from heterophilic antibodies and autoantibodies<br>8. Biotin interference in clinical laboratory tests: sporadic problem or a serious clinical issue?</p> <p>Section II: Sources of errors in clinical chemistry laboratory<br>9. Challenges in routine clinical chemistry testing analysis of small molecules<br>10. Challenges in routine clinical chemistry analysis: proteins and enzymes<br>11. Challenges in endocrinology testing<br>12. Pitfalls in testing for common tumor markers</p> <p>Section III: Sources of errors in therapeutic drug monitoring and toxicology<br>13. Issues of interferences in therapeutic drug monitoring<br>14. Limitations of immunoassays for screening of drugs of abuse in urine: issues of false positive and false negative results<br>15. Challenges in confirmation testing for drugs of abuse<br>16. Issues of false negative results in toxicology: difficult in detecting certain drugs and issues with detection of synthetic cathinone (bath salts), synthetic cannabinoids (spice), and other new psychoactive substances<br>17. Ethanol determination using automated analyzers: limitations and pitfalls</p> <p>Section IV: Herbal medicines and laboratory testings<br>18. Effects of herbal supplements on clinical laboratory test results</p> <p>Section V: Sources of errors in immunology laboratory<br>19. Critical issues in hemoglobinopathy detection and serology testing for HIV and hepatitis infections<br>20. Sources of errors in immunology and serology testing</p> <p>Section VI: Sources of errors in molecular, genetic and related testings<br>21. Sources of error in molecular diagnostic analyses<br>22. Molecular testing for targeted therapies and pharmacogenomics<br>23. Challenges and sources of inaccuracy in biochemical genetics testing</p> <p>Section VII: Sources of errors in microbiology testings<br>24. Sources of pre-analytical, analytical and post-analytical errors in the microbiology laboratory</p> <p>Section VIII: Sources of errors in hematology and coagulation testings<br>25. Sources of errors in hematology testing<br>26. Sources of errors in coagulation testing<br>27. Sources of errors in flow cytometry</p> <p>Section IX: Sources of errors in transfusion medicine<br>28. Interferences in blood bank testing<br>29. Errors and adverse effects of blood transfusion<br>30. Methodological issues in point of care testing devices<br>31. Special concern: sources of inaccuracy in breath alcohol analysis</p>